Back to NBIX
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND → NBIX
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$16.5M
Q3 2026
Peak value
$16.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.2M |
| Q4 2025 | $5M |
| Q1 2026 | $8.5M |
| Q2 2026 | $12.9M |
| Q3 2026 | $16.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $16.5M | 116.4K | — | — |
| Q2 2026 | $12.9M | 76.6K | — | — |
| Q1 2026 | $8.5M | 64.2K | — | — |
| Q4 2025 | $5M | 35.2K | — | — |
| Q3 2025 | $5.2M | 37.2K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M